Active ingredientLacidipineCat. No. P-L002-001CAS 103890-78-4Family · Pharmaceutical analytical standards
Lacidipine
A dihydropyridine calcium channel blocker that widens blood vessels by blocking L-type calcium channels; patented in 1984 and in use since 1991 for high blood pressure. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?It is so lipophilic that it accumulates in cell membranes and is slowly released from there towards its target: this is why it acts gradually and its effect lasts all day.
Go to the active ingredient →Active ingredientLacidipineCat. No. P-L002-001CAS 103890-78-4
Pharmacopoeial impurityLacidipine EP Impurity BCat. No. P-L002-002CAS 130996-24-6
Isotopically labelledLacidipine-d10Cat. No. P-L002-003CAS 1185245-62-8
Impurity(E)-tert-butyl3-(2-formylphenyl)acrylateCat. No. P-L002-005CAS 103890-69-3
Impurity2-EthenylbenzaldehydeCat. No. P-L002-006CAS 28272-96-0
Impuritycis-LacidipineCat. No. P-L002-007CAS 103890-79-5
ImpurityLacidipine Impurity 1Cat. No. P-L002-008
ImpurityLacidipine Impurity 2Cat. No. P-L002-009
ImpurityLacidipine Impurity 3Cat. No. P-L002-010
ImpurityLacidipine Impurity 4Cat. No. P-L002-011
ImpurityLacidipine Monomethyl EsterCat. No. P-L002-012CAS 103890-81-9No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.